Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 3
1995 6
1996 11
1997 3
2001 1
2002 11
2003 3
2004 8
2005 4
2006 7
2007 7
2008 3
2009 8
2010 7
2011 4
2012 10
2013 11
2014 5
2015 1
2016 1
2017 1
2018 2
2019 1
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Molecular mechanisms of cisplatin resistance.
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Galluzzi L, et al. Among authors: castedo m. Oncogene. 2012 Apr 12;31(15):1869-83. doi: 10.1038/onc.2011.384. Epub 2011 Sep 5. Oncogene. 2012. PMID: 21892204 Review.
Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G. Obeid M, et al. Among authors: castedo m. Nat Med. 2007 Jan;13(1):54-61. doi: 10.1038/nm1523. Epub 2006 Dec 24. Nat Med. 2007. PMID: 17187072
Mitochondrial gateways to cancer.
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. Galluzzi L, et al. Among authors: castedo m. Mol Aspects Med. 2010 Feb;31(1):1-20. doi: 10.1016/j.mam.2009.08.002. Epub 2009 Aug 19. Mol Aspects Med. 2010. PMID: 19698742 Review.
Metabolic vulnerability of cisplatin-resistant cancers.
Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G. Obrist F, et al. Among authors: castedo m. EMBO J. 2018 Jul 13;37(14):e98597. doi: 10.15252/embj.201798597. Epub 2018 Jun 6. EMBO J. 2018. PMID: 29875130 Free PMC article.
Predictive biomarkers for cancer therapy with PARP inhibitors.
Michels J, Vitale I, Saparbaev M, Castedo M, Kroemer G. Michels J, et al. Among authors: castedo m. Oncogene. 2014 Jul 24;33(30):3894-907. doi: 10.1038/onc.2013.352. Epub 2013 Sep 16. Oncogene. 2014. PMID: 24037533 Review.
Immunosurveillance against cancer-associated hyperploidy.
Senovilla L, Galluzzi L, Marino G, Vitale I, Castedo M, Kroemer G. Senovilla L, et al. Among authors: castedo m. Oncotarget. 2012 Nov;3(11):1270-1. doi: 10.18632/oncotarget.753. Oncotarget. 2012. PMID: 23174699 Free PMC article. No abstract available.
Mitochondrion-targeted apoptosis regulators of viral origin.
Boya P, Roumier T, Andreau K, Gonzalez-Polo RA, Zamzami N, Castedo M, Kroemer G. Boya P, et al. Among authors: castedo m. Biochem Biophys Res Commun. 2003 May 9;304(3):575-81. doi: 10.1016/s0006-291x(03)00630-2. Biochem Biophys Res Commun. 2003. PMID: 12729592 Review.
119 results